J L Rueda García

62 - SEGURIDAD Y EFECTIVIDAD DE LAS TERAPIAS AVANZADAS EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL Y CIRROSIS COMPENSADA. DATOS PRELIMINARES DEL ESTUDIO HEP-IBD. UN ESTUDIO DEL GRUPO JOVEN DE GETECCU

Esteban Fuentes-Valenzuela, Lucía Madero, Ana Suárez Saro, Carlos Maroto Martin et autres

Towards tailored surveillance strategies in inflammatory bowel disease: still a long way to go

J L Rueda García, M. Löwenberg

Low-grade dysplasia (LGD) in inflammatory bowel disease (IBD) is a well-recognized risk factor for advanced colorectal neoplasia, which includes high-grade dysplasia (HGD) and colorectal cancer (CRC).1 Consequently, guidelines recommend stringent endoscopic surveillance intervals in IBD patients with a history of LGD.2 Disease …

es, nl (code pays fourni par la source)

Evaluación de la remisión histológica en colitis ulcerosa mediante endocitoscopia

Cristina Suárez Ferrer, Eduardo Martin Arranz, J L Rueda García, María Sánchez Azofra et autres

Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn’s Disease

J L Rueda García, Cristina Suárez Ferrer, Clara Amiama Roig, Laura García Ramírez et autres

Background: Therapeutic drug monitoring of adalimumab (ADA) is still controversial. Objectives: To study the association between ADA trough levels in the early stages of treatment with biological remission (BR) and drug survival in Crohn's disease (CD). Design: Retrospective cohort study. Methods: Patients …

es (code pays fourni par la source)

Comparison of endoscopic ultrasound (EUS)-guided fine needle aspiration with and without rapid onsite evaluation of cytopathology (ROSE) in solid lesions

Carmen Amor Costa, Gloria Ruiz Fernández, J L Rueda García, Consuelo Froilán Torres et autres

Aims Endoscopic ultrasound (EUS) and fine-needle aspiration (FNA) are the gold standard techniques for the diagnosis of solid pancreatic and peripancreatic lesions [ 1 ]. The reported diagnostic yield of EUS-FNA is approximately 78% [ 2 ], and the benefit of rapid …

es (code pays fourni par la source)

Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease

Carmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, Eduardo Martín-Arranz et autres

es (code pays fourni par la source)

P1081 Correlation of vedolizumab levels with medium-and long-term response in patients with Inflammatory Bowel Disease

María Hernández‐Pérez, C J Suarez Ferrer, L García-Ramírez, Eduardo Martín-Arranz et autres

Abstract Background Drug level monitoring is standard practice for anti-TNF therapies (1,2). In the case of vedolizumab, pivotal studies suggest a similar relationship (3,4) although real-world studies are needed. This study aimed to investigate the relationship between vedolizumab levels during the induction …

es (code pays fourni par la source)

P1240 Overweight in patients with inflammatory bowel disease and the associated risk of malnutrition

C J Suarez Ferrer, C Cubillo García, C Garcia-Rojas Pleite, J L Rueda García et autres

Abstract Background Although inflammatory bowel disease(IBD) has traditionally been associated with malnutrition,the prevalence of overweight(0W)and obesity is currently increasing.Moreover, both overweight and chronic inflammation can elevate the risk of essential micronutrient deficiencies.The objective of this study is to investigate the prevalence of …

es (code pays fourni par la source)

P0322 Global coagulation assays for the assessment of hypercoagulable states in Inflammatory Bowel Diseases.

J L Rueda García, Elena Monzón Manzano, Paula Acuña, Eduardo Martin Arranz et autres

Abstract Background Inpatients with Inflammatory Bowel Disease (IBD) are at risk for thromboembolic events, but the risk for flaring outpatients is less understood1. Global Coagulation Assays (GCA) (Thrombin generation assay using Calibrated Automated Thrombogram [CAT] and Rotational Thromboelastometry [ROTEM]) have emerged as …

es (code pays fourni par la source)

P0411 Utility of Intestinal Ultrasound as a predictor of Severe Ulcerative Colitis response to treatment

Silvia María Artacho Criado, Cristina Suárez Ferrer, Joaquín Poza Cordón, Laura García Ramírez et autres

Abstract Background Severe Acute Ulcerative Colitis (ASUC) is a serious complication of UC that requires an early response to treatment assessment and which clinical and analytical evaluations are often inadequate. In this setting, intestinal ultrasound (IUS) could be helpful, given its accuracy …

es (code pays fourni par la source)

DOP003 Cromoendoscopy versus second generation Narrow band Imaging for dysplasia detection in IBD. A prospective randomized controlled trial

Eduardo Arranz, Cristina Suárez Ferrer, Laura García Ramírez, María Sánchez Azofra et autres

Abstract Background Neoplastic risk is increased in long-standing colitis. Dye chromoendoscopy (CE) and virtual chromoendoscopy are surveillance methods. The aim of this trial is to compare methylene blue chromoendoscopy (CE) with second generation narrow band imaging (NBI) virtual chromoendoscopy in the detection …

es (code pays fourni par la source)

P-57 - SOBREPESO EN ENFERMEDAD INFLAMATORIA INTESTINAL: ¿UN FACTOR DE RIESGO PARA LA MALNUTRICIÓN?

Cristina Suárez Ferrer, Isabel Martorrel Mariné, J L Rueda García, Laura García Ramírez et autres